Logo image
Elucidating the mechanisms of EHE transformation
Dissertation   Open access

Elucidating the mechanisms of EHE transformation

Nicholas Philip Scalora
University of Iowa
Doctor of Philosophy (PhD), University of Iowa
Summer 2024
DOI: 10.25820/etd.007683
pdf
Nicholas Scalora_Thesis_Final4.34 MBDownloadView
Open Access Free to read and download

Abstract

The Hippo signaling pathway regulates many key cellular processes including cell growth, apoptosis, and differentiation. The downstream effectors of the Hippo pathway, TAZ (transcriptional coactivator with PDZ-binding motif) and YAP (yes associated protein), are transcriptional coactivators that need to complex with Tea Domain (TEAD) family of transcription factors to drive their transcriptional program. This pathway is disrupted in many cancers, including sarcomas, leading to hyperactive TAZ and YAP. One mechanism TAZ and YAP can avoid regulation is by chromosomal translocation events resulting in the expression of novel chimeric proteins. Specifically, a TAZ-CAMTA1 or YAP-TFE3 fusion protein drives the vascular sarcoma epithelioid hemangioendothelioma (EHE). Understanding the mechanisms by which these fusion proteins drive cellular transformation may lead to better therapies for EHE, and potentially extend to other cancers that have activated TAZ or YAP. In chapter 2, I focus on the generation and characterization of the first human EHE extended primary cell cultures. I demonstrated expression of the TAZ-CAMTA1 fusion protein by qRTPCR, expression of CAMTA1 by single-cell RNA seq, and expression at the protein level by probing for TAZ and observing a shift in molecular weight to what is expected for the fusion protein. I found that the EHE primary cell cultures proliferate faster than primary endothelial cells in 2D culture and drive anchorage-independent growth in soft agar and poly-HEMA. Analysis of genomic alterations in the cell cultures showed a low mutational burden, corroborating previously established literature. Upregulated pathways defined by RNA-seq in EHE tumors are conserved in primary cell cultures by RNA-seq. Additionally, I have shown that the extended primary cell cultures have not spontaneously immortalized and senescence around passage 20, suggesting other alterations besides TAZ and YAP fusion protein expression are needed to drive full transformation. In chapter 3, I sought to identify other cofactors necessary for EHE cellular transformation. I found that topoisomerase II (TOP2) is required for YAP-TFE3 and TAZ-CAMTA1 mediated anchorage-independent growth. This stems from a high-throughput screen of 1,000 FDA approved compounds in which 4/6 that reduced spheroid size by the greatest amount are TOP2 inhibitors. Follow-up studies by genetic knockdown of TOP2 show a decrease in anchorage-independent growth, a key phenotype driven by the fusions, but no decreases in 2D proliferation. TOP2 has a variety of cellular functions including alleviating supercoiling that occurs during DNA transcription and replication. Emerging literature suggests that TOP2 aids in regulating chromatin topological associated domains, in part through chromatin looping, and impacts transcription. While TOP2 inhibitors are used clinically to treat a variety of cancers including sarcomas, they are used judiciously because of cardiotoxic side effects. A greater understanding of the mechanisms driving EHE transformation is required to generate better therapies. The work presented in this thesis describes and characterizes the first human EHE extended primary cell cultures. I also identified topoisomerase II as a cofactor and potential therapeutic vulnerability in EHE, likely by regulation of YAP-TFE3 and TAZ-CAMTA1 transcription. Overall, the findings discussed in this thesis provide rationale for exploring new therapeutic options to target EHE and describe a new cell-based model to facilitate new discoveries.
Epithelioid hemangioendothelioma Hippo Pathway Sarcoma TAZ Topoisomerase II YAP Cellular biology

Details

Metrics

4 File views/ downloads
32 Record Views
Logo image